Showing results (1471-1480 of 1,593) with videos related to

Sort By:
Pageof 160
JCO Oncology Practice|January 29, 2026
Regional Audit and Feedback Intervention to Improve Quality of Care in Ovarian Cancer Treatment: The Easy-Net ExperienceElisa Piovano, Annamaria Ferrero, Giovannino Ciccone, et al.
JCO Oncology Practice|December 10, 2025
Timing of Durvalumab Consolidation and Survival in Non-Small Cell Lung Cancer: A Population-Based AnalysisTawee Tanvetyanon, Dung-Tsa Chen, Jhanelle E Gray
JCO Oncology Practice|December 5, 2025
Characterizing Survivors Living With Likely Incurable Cancer: A Closer Look at an Emerging PopulationShivani Sharma, Jennifer Dahne, Lisa Gallicchio, et al.
JCO Oncology Practice|November 24, 2025
Under-Representation of Black and Hispanic Men in Metastatic Castration-Resistant Prostate Cancer Trials (2005-2021): A Call to ActionCanan D Dirican, Sagar Patel, Anas Al Mardini, et al.
JCO Oncology Practice|November 24, 2025
Predictors of Successful Neoadjuvant Chemotherapy and Interval Cytoreductive Surgery in Management of Ovarian CancerClaudia Marchetti, Gwenael Ferron, Olivier Colomban, et al.
JCO Oncology Practice|November 18, 2025
Accuracy of Computed Tomography Staging of Mismatch Repair-Deficient Colon CancerSamantha M Linhares, Thejal Srikumar, Clifford Shin, et al.
JCO Oncology Practice|November 18, 2025
Systemic Therapy for Muscle-Invasive Urothelial Carcinoma of the Bladder (Muscle-Invasive Bladder Cancer): Insights From Real-World DataSarmad Sadeghi, Primo N Lara, Andrea Necchi, et al.
JCO Oncology Practice|December 4, 2025
Outpatient Administration of Bispecific Antibody Therapy for Hematologic Malignancies: A Practical GuideKian J Rahbari, Raul Del Toro Mijares, Kathryn Kennedy, et al.
JCO Oncology Practice|December 17, 2024
Efficacy of Subsequent Treatments After Disease Progression on CDK4/6 Inhibitors in Patients With Hormone Receptor-Positive Advanced Breast CancerLis Victoria Ravani, Pedro Calomeni, Maysa Vilbert, et al.
JCO Oncology Practice|December 19, 2024
Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is NowNeal Shore, Sarah M Nielsen, Edward D Esplin, et al.
Pageof 160